Cargando…
Ovulatory upregulation of angiotensin-converting enzyme 2, a receptor for SARS-CoV-2, in dominant follicles of the human ovary
OBJECTIVE: To determine the temporal expression of angiotensin-converting enzyme 2 (ACE2), a receptor for SARS-CoV-2, in dominant follicles throughout the periovulatory period in women and the regulatory mechanisms underlying ACE2 expression in human granulosa/lutein cells (hGLC). DESIGN: Experiment...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Reproductive Medicine, Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354803/ https://www.ncbi.nlm.nih.gov/pubmed/34538460 http://dx.doi.org/10.1016/j.fertnstert.2021.08.009 |
_version_ | 1783736655898738688 |
---|---|
author | Choi, Yohan Jeon, Hayce Brännström, Mats Akin, James W. Curry, Thomas E. Jo, Misung |
author_facet | Choi, Yohan Jeon, Hayce Brännström, Mats Akin, James W. Curry, Thomas E. Jo, Misung |
author_sort | Choi, Yohan |
collection | PubMed |
description | OBJECTIVE: To determine the temporal expression of angiotensin-converting enzyme 2 (ACE2), a receptor for SARS-CoV-2, in dominant follicles throughout the periovulatory period in women and the regulatory mechanisms underlying ACE2 expression in human granulosa/lutein cells (hGLC). DESIGN: Experimental prospective clinical study and laboratory-based investigation. SETTING: University Medical Center and private in vitro fertilization center. PATIENT(S): Thirty premenopausal women undergoing surgery for tubal ligation and 16 premenopausal women undergoing in vitro fertilization. INTERVENTION(S): Administration of human chorionic gonadotropin (hCG) and harvesting of preovulatory/ovulatory follicles by timed laparoscopy, and collection of granulosa/lutein cells and cumulus cells at the time of oocyte retrieval. MAIN OUTCOME MEASURE(S): Expression and localization of ACE2 in granulosa cells and dominant follicles collected throughout the periovulatory period of the menstrual cycle and in hGLC using quantitative polymerase chain reaction, immunoblotting, and immunohistochemistry. RESULT(S): ACE2 expression (mRNA and protein) is up-regulated in human ovulatory follicles after administration of hCG. ACE2 expression was higher in cumulus cells than in granulosa cells. hCG increased the expression of ACE2 in primary hGLC cultures; the increase was inhibited by RU486 (an antagonist for progesterone receptor and glucocorticoid receptor) and CORT125281 (a selective glucocorticoid receptor antagonist), but not by AG1478 (an EGF receptor tyrosine kinase inhibitor) or by dexamethasone. CONCLUSION(S): The hormone-regulated expression of ACE2 in granulosa cells suggests a potential role of ACE2 in the ovulatory process. These data also imply the possible impact of COVID-19 on a vital cyclic event of ovarian function and thus on women's overall reproductive health. However, SAR-CoV-2 infection in ovarian cells in vivo or in vitro has yet to be determined. |
format | Online Article Text |
id | pubmed-8354803 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Society for Reproductive Medicine, Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83548032021-08-11 Ovulatory upregulation of angiotensin-converting enzyme 2, a receptor for SARS-CoV-2, in dominant follicles of the human ovary Choi, Yohan Jeon, Hayce Brännström, Mats Akin, James W. Curry, Thomas E. Jo, Misung Fertil Steril Original Article OBJECTIVE: To determine the temporal expression of angiotensin-converting enzyme 2 (ACE2), a receptor for SARS-CoV-2, in dominant follicles throughout the periovulatory period in women and the regulatory mechanisms underlying ACE2 expression in human granulosa/lutein cells (hGLC). DESIGN: Experimental prospective clinical study and laboratory-based investigation. SETTING: University Medical Center and private in vitro fertilization center. PATIENT(S): Thirty premenopausal women undergoing surgery for tubal ligation and 16 premenopausal women undergoing in vitro fertilization. INTERVENTION(S): Administration of human chorionic gonadotropin (hCG) and harvesting of preovulatory/ovulatory follicles by timed laparoscopy, and collection of granulosa/lutein cells and cumulus cells at the time of oocyte retrieval. MAIN OUTCOME MEASURE(S): Expression and localization of ACE2 in granulosa cells and dominant follicles collected throughout the periovulatory period of the menstrual cycle and in hGLC using quantitative polymerase chain reaction, immunoblotting, and immunohistochemistry. RESULT(S): ACE2 expression (mRNA and protein) is up-regulated in human ovulatory follicles after administration of hCG. ACE2 expression was higher in cumulus cells than in granulosa cells. hCG increased the expression of ACE2 in primary hGLC cultures; the increase was inhibited by RU486 (an antagonist for progesterone receptor and glucocorticoid receptor) and CORT125281 (a selective glucocorticoid receptor antagonist), but not by AG1478 (an EGF receptor tyrosine kinase inhibitor) or by dexamethasone. CONCLUSION(S): The hormone-regulated expression of ACE2 in granulosa cells suggests a potential role of ACE2 in the ovulatory process. These data also imply the possible impact of COVID-19 on a vital cyclic event of ovarian function and thus on women's overall reproductive health. However, SAR-CoV-2 infection in ovarian cells in vivo or in vitro has yet to be determined. American Society for Reproductive Medicine, Published by Elsevier Inc. 2021-12 2021-08-11 /pmc/articles/PMC8354803/ /pubmed/34538460 http://dx.doi.org/10.1016/j.fertnstert.2021.08.009 Text en ©2021 American Society for Reproductive Medicine, Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Original Article Choi, Yohan Jeon, Hayce Brännström, Mats Akin, James W. Curry, Thomas E. Jo, Misung Ovulatory upregulation of angiotensin-converting enzyme 2, a receptor for SARS-CoV-2, in dominant follicles of the human ovary |
title | Ovulatory upregulation of angiotensin-converting enzyme 2, a receptor for SARS-CoV-2, in dominant follicles of the human ovary |
title_full | Ovulatory upregulation of angiotensin-converting enzyme 2, a receptor for SARS-CoV-2, in dominant follicles of the human ovary |
title_fullStr | Ovulatory upregulation of angiotensin-converting enzyme 2, a receptor for SARS-CoV-2, in dominant follicles of the human ovary |
title_full_unstemmed | Ovulatory upregulation of angiotensin-converting enzyme 2, a receptor for SARS-CoV-2, in dominant follicles of the human ovary |
title_short | Ovulatory upregulation of angiotensin-converting enzyme 2, a receptor for SARS-CoV-2, in dominant follicles of the human ovary |
title_sort | ovulatory upregulation of angiotensin-converting enzyme 2, a receptor for sars-cov-2, in dominant follicles of the human ovary |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354803/ https://www.ncbi.nlm.nih.gov/pubmed/34538460 http://dx.doi.org/10.1016/j.fertnstert.2021.08.009 |
work_keys_str_mv | AT choiyohan ovulatoryupregulationofangiotensinconvertingenzyme2areceptorforsarscov2indominantfolliclesofthehumanovary AT jeonhayce ovulatoryupregulationofangiotensinconvertingenzyme2areceptorforsarscov2indominantfolliclesofthehumanovary AT brannstrommats ovulatoryupregulationofangiotensinconvertingenzyme2areceptorforsarscov2indominantfolliclesofthehumanovary AT akinjamesw ovulatoryupregulationofangiotensinconvertingenzyme2areceptorforsarscov2indominantfolliclesofthehumanovary AT currythomase ovulatoryupregulationofangiotensinconvertingenzyme2areceptorforsarscov2indominantfolliclesofthehumanovary AT jomisung ovulatoryupregulationofangiotensinconvertingenzyme2areceptorforsarscov2indominantfolliclesofthehumanovary |